Fredun Pharmaceuticals announced significant milestones in its business expansion and product development initiatives.
It has received orders from Southeast Asian (SEA) countries, amounting to Rs 28 crores. These orders demonstrate the company’s growing presence in the international markets and hold substantial potential to scale up over the years.
In pet and veterinary care segment, Fredun Pharma has initiated the development of three new molecules. These formulations address critical needs and enhance the well-being of companion animals, informed the company.
Building on the success of its bone graft products, Fredun Pharma is also expanding its focus on bone grafts for use in orthopaedic and veterinary applications.